Abbott Laboratories buy Royal Bank of Canada
Start price
19.04.24
/
50%
€98.67
Target price
19.04.25
€117.41
Performance (%)
0.63%
Price
30.04.24
€99.29
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Abbott Laboratories is nearly unchanged. This prediction currently runs until 19.04.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Abbott Laboratories | -0.601% |
| iShares Core DAX® | -0.992% |
| iShares Nasdaq 100 | -0.225% |
| iShares Nikkei 225® | -0.736% |
| iShares S&P 500 | -0.509% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Royal Bank of Canada from $128.00 to $125.00. They now have an "outperform" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€104.16
14.02.24
14.02.24
€119.35
14.02.25
14.02.25
-4.18%
30.04.24
30.04.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.54
25.01.24
25.01.24
€118.09
25.01.25
25.01.25
-2.67%
30.04.24
30.04.24
Abbott Laboratories
Start price
Target price
Perf. (%)
€102.98
11.01.24
11.01.24
€116.90
11.01.25
11.01.25
-2.59%
30.04.24
30.04.24